Discovery and optimization of 1-(4-(pyridin-2-yl)benzyl)imidazolidine-2,4-dione derivatives as a novel class of selective cannabinoid CB2 receptor agonists.
about
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilitiesDiscovery of novel small molecule activators of β-catenin signalingThe novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicity.Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity.Selective Photoaffinity Probe That Enables Assessment of Cannabinoid CB2 Receptor Expression and Ligand Engagement in Human Cells.Evaluation of different drug classes on transient sciatic nerve injury-depressed marble burying in mice.
P2860
Discovery and optimization of 1-(4-(pyridin-2-yl)benzyl)imidazolidine-2,4-dione derivatives as a novel class of selective cannabinoid CB2 receptor agonists.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Discovery and optimization of ...... abinoid CB2 receptor agonists.
@en
Discovery and optimization of ...... abinoid CB2 receptor agonists.
@nl
type
label
Discovery and optimization of ...... abinoid CB2 receptor agonists.
@en
Discovery and optimization of ...... abinoid CB2 receptor agonists.
@nl
prefLabel
Discovery and optimization of ...... abinoid CB2 receptor agonists.
@en
Discovery and optimization of ...... abinoid CB2 receptor agonists.
@nl
P2093
P921
P356
P1476
Discovery and optimization of ...... abinoid CB2 receptor agonists.
@en
P2093
Angela King
Antoon A van der Doelen
Ilse Pols-de Rooij
James Baker
Jean Cottney
Jeroen de Roos
Julia Oosterom
Marcel Hermkens
P304
P356
10.1021/JM200916P
P407
P577
2011-09-29T00:00:00Z